Skip to content

Rafael Holdings, Inc. RFL Acquired in-process research and development

Acquired in-process research and development at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$250K+144%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA

Segments

By segment

See full
Healthcare One$4.85M+61.6%

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Reported directly by Rafael Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s acquired in-process research and development.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s acquired in-process research and development?
Rafael Holdings, Inc. (RFL) reported acquired in-process research and development of $4.85M in Q1 2026.
How has Rafael Holdings, Inc.'s acquired in-process research and development changed year-over-year?
Rafael Holdings, Inc.'s acquired in-process research and development increased by 61.6% year-over-year, from $3M to $4.85M.
What is the long-term trend for Rafael Holdings, Inc.'s acquired in-process research and development?
Over 4 years (2021 to 2025), Rafael Holdings, Inc.'s acquired in-process research and development has grown at a 2.9% compound annual growth rate (CAGR), from $4.91M to $5.51M.
What does acquired in-process research and development mean?
Reflects the capital expenditure or purchase price allocated to acquiring research and development projects that are currently in progress and have not yet reached technological feasibility. This is a critical indicator of a company's strategy to expand its product pipeline through external acquisitions rather than purely internal development.